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Abstract
Purpose : To report the results obtained in a series of 58 eyes with chronic corneal
ulcers and persistent epithelial defects resistant to conventional therapy and treated
with 0.01% poly-carboxymethylglucose sulfate (RGTA, Cacicol ).
Methods : A prospective study was made of 58 eyes of patients with corneal ulcers and
persistent epithelial lesions secondary to neurotrophic disorders, caustic damage,
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keratitis and severe dry eye, among other conditions. The ulcers were essentially
chronic and slow-evolving, with mean vertical and horizontal diameters of 2.4 and 2.7
mm, respectively (range 1-5.5 mm). All patients had been previously treated with
classical tear substitutes, and some had also received blood products, topical
cyclosporine, corticosteroids, amniotic membrane coverings, therapeutic contact lenses
and/or a vitamin-based eye ointment. The patients received an initial dose of one drop
in the morning every 48 hours during 10 days. After evaluation of the e ects of
treatment, new dosing schemes were prescribed for those patients who had improved
their clinical condition though without complete resolution of the disease.
Results : Important variation was observed in the time to recovery of corneal integrity,
ranging from a few days to some weeks, depending on the severity and etiology of the
case. Full healing was recorded in 50 patients. The patients with large neurotrophic
ulcers showed improvement of the lesions, with a decrease in lesion size after 15 days
of treatment. Eight eyes did not achieve complete healing. In the case of severe
ulceration and when a positive e ect was observed after one month, treatment was
continued with spacing of the applications until complete healing was achieved. All
patients reported subjective improvement. The drug showed immediate e cacy in 11
eyes with epithelialisation disorders following PRK or trauma, with recovery of tissue
integrity after the  rst treatment period.
Conclusions : The tissue regenerating agent (RGTA, Cacicol ) is an interesting and
e ective topical adjuvant product for the treatment of severe and chronic corneal
ulcers resistant to conventional treatment. Its e cacy remains to be con rmed in the
context of double-blind, randomised clinical trials.
This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in
Seattle, Wash., May 1-5, 2016.
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